Keywords: EU Commission, Lundbeck, Antitrust, Citalopram

EU Commission opens formal antitrust proceedings against Danish drugmaker Lundbeck

Article | 07 January 2010

Print This

As part of its ongoing questioning of the activities of European pharmaceutical companies, which have, over the past, included “dawn ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in